Mitopure™ (Proprietary Urolithin A) Bioavailability in Healthy Adults
Launched by AMAZENTIS SA · Nov 8, 2019
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Males and females 18 to 80 years of age;
- • 2. Is in general good health, as determined by the clinical research team;
- • 3. Willingness to consume investigational product, complete questionnaires and to complete all clinic visits;
- • 4. Have given voluntary, written, informed consent to participant in the study;
- Exclusion Criteria:
- • 1. Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial;
- • 2. Alcohol or drug abuse within the last 6 months;
- • 3. Volunteers who plan to donate blood during the study or within 30 days of completing the study;
- • 4. Subject has a known allergy to the test material's active or inactive ingredients;
- • 5. Subjects with unstable medical conditions;
- • 6. Clinically significant abnormal laboratory results at screening;
- • 7. Participation in a clinical research trial within 30 days prior to randomization;
- • 8. Allergy or sensitivity to study ingredients; lactose intolerance.
- • 9. Individuals who are cognitively impaired and/or who are unable to give informed consent;
- • 10. Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject.
- • 11. Has taken antibiotics within the previous 30 days;
About Amazentis Sa
Amazentis SA is a biotechnology company focused on advancing health through the development of innovative nutritional and therapeutic solutions. With a strong emphasis on scientific research and clinical validation, Amazentis leverages cutting-edge technologies to explore the potential of bioactive compounds in promoting metabolic health and enhancing overall well-being. The company is dedicated to transforming scientific discoveries into effective products that address pressing health challenges while maintaining a commitment to sustainability and evidence-based practices. Through strategic collaborations and rigorous clinical trials, Amazentis aims to contribute significantly to the fields of nutrition and health optimization.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Ali Keshavarzian, MD
Principal Investigator
Rush University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials